+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Cell Line Development Market by Type (Continuous Cell Lines, Hybridomas, Primary Cell Lines), Source (Amphibian, Insect, Mammalian), Product, Application - Forecast 2024-2030- Product Image
Global Cell Line Development Market by Type (Continuous Cell Lines, Hybridomas, Primary Cell Lines), Source (Amphibian, Insect, Mammalian), Product, Application - Forecast 2024-2030- Product Image
Sale

Global Cell Line Development Market by Type (Continuous Cell Lines, Hybridomas, Primary Cell Lines), Source (Amphibian, Insect, Mammalian), Product, Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4858015
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Line Development Market size was estimated at USD 5.69 billion in 2023, USD 6.49 billion in 2024, and is expected to grow at a CAGR of 14.34% to reach USD 14.54 billion by 2030.

Cell line development is a critical and complex process utilized in biological and pharmaceutical research, as well as in the production of various biologics, including vaccines, antibodies, and other therapeutic proteins. It involves the selection and optimization of host cells for the stable or transient expression of a specific gene or set of genes of interest. Typically, mammalian cells, such as Chinese hamster ovary (CHO) cells, are favored for their ability to perform post-translational modifications crucial for the function of many human proteins. The rising incidence of chronic diseases requires the development of new therapeutics, thereby creating a need for cell line development.

Additionally, increased funding in research and development by pharmaceutical companies and governments and innovations in novel gene editing technologies have promoted the growth of the industry. However, ethical issues over the use of human and animal cells can pose restrictions and lead to public scrutiny. Furthermore, ensuring the stability of cell lines over time and preserving genetic integrity presents significant challenges to the growth of the industry. However, key players are exploring the utilization of advanced technologies such as AI/ML, robotics, automation, and data analytics to simplify the process of cell line development. Additionally, the development of synthetic and artificial scaffolds for 3D cell cultures that enhance cell line growth and productivity can also create new avenues of growth for the cell line development industry.

Regional Insights

In the Americas, the demand for cell line development is primarily driven by the robust pharmaceutical and biotechnology sectors, particularly in the US and Canada. As the region continues to lead in drug discovery and biologics production, cell lines serve as crucial tools in the development of therapeutic proteins, vaccines, and biosimilars. Europe exhibits a strong and growing demand for cell line development, supported by its well-established pharmaceutical industry and a growing focus on personalized medicine.

The need for cell line development is also fueled by the European Union's stringent regulatory framework for the approval of biosimilars, which requires high-quality cell lines that are capable of producing efficacy and safety profiles similar to the reference biologic products. Collaborations between academic institutions and industry players, alongside substantial investments in biotechnology, signify the ongoing need for sophisticated cell line development in this region. The APAC region witnesses a significant need for cell line development, attributed to its expanding biopharmaceutical sector, increasing healthcare expenditure, and rising population aging. The region's need for cell line development is also influenced by the growing prevalence of infectious diseases and the resultant need for vaccines and novel therapeutic treatments. Growing government initiatives to support the development of cost-effective therapeutics are propelling the development and demand for advanced cell lines in the APAC region.

Market Trends by Segment

  • Type: Increasing adoption of continuous cell lines in research activities due to their robustness and ease of work
  • Source: Rising utilization of mammalian sources of cell lines for the production of therapeutic molecules
  • Product: Integration of advanced technologies in equipment for cell line development
  • Application: Need for scalable and reliable cell line development strategies for bioproduction

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Sphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics To Advance Cell Line Development Workflows

Sphere Fluidics, a player involved in developing single-cell analysis systems, announced that its Cyto-Mine platform had been selected by FairJourney Biologics to expand its cell line development capabilities. This agreement aims to refine and expedite client processes, allowing FairJourney Biologics to act as a comprehensive partner in the antibody sector, offering cohesive solutions from discovery and engineering to production.

Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction

Bruker Corporation announced a strategic move to enhance its presence in the life sciences sector by acquiring PhenomeX, a functional cell biology firm. The integration of PhenomeX's advanced single-cell analysis technologies has the capacity to significantly improve Bruker's capabilities, particularly in the domains of antibody therapeutics, cell line development, and both cell and gene therapies.

KBI Biopharma Unveils KBI PUREplatform, a Microbial Expression Offering for Biopharmaceutical Manufacturing

KBI Biopharma, Inc. (KBI) introduced its advanced KBI PUREplatform, which is a microbial cell line development (CLD) platform designed for biopharmaceutical production. The KBI PUREplatform tackles persistent complications such as suboptimal yield, inferior protein quality, and manufacturing bottlenecks. Clients utilizing this innovative platform can achieve substantial progress in their production processes, potentially accelerating the path to market and reducing costs for both producers and, ultimately, patients.

Key Company Profiles

The report delves into recent significant developments in the Cell Line Development Market, highlighting leading vendors and their innovative profiles. These include Advanced Instruments, LLC, AGC Biologics, Aragen Life Sciences Ltd., Boehringer Ingelheim International GmbH, Catalent, Inc., Corning Incorporated, Cyagen, Danaher Corporation, EuBiologics Co.,Ltd., Eurofins Scientific, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., GE HealthCare Technologies Inc., GenScript Biotech Corporation, KBI Biopharma by JSR Life Sciences, LLC, Lonza Group Ltd., Merck KGaA, Novartis AG, PromoCell GmbH, Rentschler Biopharma SE, Samsung Biologics Co., Ltd., Sartorius AG, Syngene International Ltd., Thermo Fisher Scientific Inc., Vista Biologicals Corporation, and WuXi Biologics Co., Ltd.

This research report offers invaluable insights into various crucial aspects of the Cell Line Development Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase Demand for Monoclonal Antibodies Owing to Increase Application
5.1.1.2. Innovative Technologies Coupled with Increased Participation of Research Institutes and Government Agency
5.1.1.3. Growing Rise in Vaccine Production
5.1.2. Restraints
5.1.2.1. Limited Awareness and High Cost Associated with The Product and Applications
5.1.3. Opportunities
5.1.3.1. Increasing Risk of Communicable Epidemics Diseases
5.1.3.2. Potential in Low-income Countries
5.1.4. Challenges
5.1.4.1. Developing Authentic and Stable Cell Lines
5.2. Market Segmentation Analysis
5.2.1. Type: Increasing adoption of continuous cell lines in research activities due to their robustness and ease of work
5.2.2. Source: Rising utilization of mammalian sources of cell lines for the production of therapeutic molecules
5.2.3. Product: Integration of advanced technologies in equipment for cell line development
5.2.4. Application: Need for scalable and reliable cell line development strategies for bioproduction
5.3. Market Trend Analysis
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
5.9. Client Customization
5.9.1. Technology Advancement
5.9.1.1. Methotrexate Amplification Technology
5.9.1.2. Glutamine Synthatase Technology
5.9.1.3. Viral-Based Technology
6. Cell Line Development Market, by Type
6.1. Introduction
6.2. Continuous Cell Lines
6.3. Hybridomas
6.4. Primary Cell Lines
6.5. Recombinant Cell Lines
7. Cell Line Development Market, by Source
7.1. Introduction
7.2. Amphibian
7.3. Insect
7.4. Mammalian
8. Cell Line Development Market, by Product
8.1. Introduction
8.2. Equipment
8.3. Media and Reagents
9. Cell Line Development Market, by Application
9.1. Introduction
9.2. Bioproduction
9.3. Drug Discovery
9.4. Research
9.5. Tissue Engineering & Regenerative Medicine
9.6. Toxicity Testing
10. Americas Cell Line Development Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Line Development Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Cell Line Development Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Sphere Fluidics’ Cyto-Mine System Selected by FairJourney Biologics To Advance Cell Line Development Workflows
13.3.2. Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction
13.3.3. KBI Biopharma Unveils KBI PUREplatform, a Microbial Expression Offering for Biopharmaceutical Manufacturing
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. CELL LINE DEVELOPMENT MARKET RESEARCH PROCESS
FIGURE 2. CELL LINE DEVELOPMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. CELL LINE DEVELOPMENT MARKET DYNAMICS
FIGURE 7. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 12. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 14. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. CELL LINE DEVELOPMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. CELL LINE DEVELOPMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. CELL LINE DEVELOPMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY CONTINUOUS CELL LINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY CONTINUOUS CELL LINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY HYBRIDOMAS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY HYBRIDOMAS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY PRIMARY CELL LINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY PRIMARY CELL LINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY RECOMBINANT CELL LINES, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY RECOMBINANT CELL LINES, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY AMPHIBIAN, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY AMPHIBIAN, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY INSECT, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY INSECT, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MAMMALIAN, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY AUTOMATED SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOREACTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOSAFETY CABINETS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY CELL COUNTERS AND VIABILITY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY CELL COUNTERS AND VIABILITY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY CENTRIFUGES, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY FILTRATION SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY INCUBATORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MICROSCOPES, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 50. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 51. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 52. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 53. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 54. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 55. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 56. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 57. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MINIMUM ESSENTIAL MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 58. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY MINIMUM ESSENTIAL MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 59. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REDUCED SERUM MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 60. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REDUCED SERUM MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 61. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 62. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 63. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 64. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 65. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 66. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 67. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY BUFFERS AND CHEMICALS, BY REGION, 2018-2023 (USD MILLION)
TABLE 68. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY BUFFERS AND CHEMICALS, BY REGION, 2024-2030 (USD MILLION)
TABLE 69. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 70. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY CELL DISSOCIATION REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 71. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY CRYOPRESERVATIVE REAGENTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 72. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY CRYOPRESERVATIVE REAGENTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 73. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SUPPLEMENTS AND GROWTH FACTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 74. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SUPPLEMENTS AND GROWTH FACTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 75. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, BY REGION, 2018-2023 (USD MILLION)
TABLE 76. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, BY REGION, 2024-2030 (USD MILLION)
TABLE 77. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 78. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 79. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY ADULT BOVINE SERUM, BY REGION, 2018-2023 (USD MILLION)
TABLE 80. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY ADULT BOVINE SERUM, BY REGION, 2024-2030 (USD MILLION)
TABLE 81. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2018-2023 (USD MILLION)
TABLE 82. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY FETAL BOVINE SERUM, BY REGION, 2024-2030 (USD MILLION)
TABLE 83. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 86. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 87. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 88. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 89. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 90. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 91. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY RECOMBINANT PROTEIN THERAPEUTICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 92. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY RECOMBINANT PROTEIN THERAPEUTICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 93. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2018-2023 (USD MILLION)
TABLE 94. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY VACCINE PRODUCTION, BY REGION, 2024-2030 (USD MILLION)
TABLE 95. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
TABLE 96. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
TABLE 97. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 98. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 99. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY DISEASE MODELING, BY REGION, 2018-2023 (USD MILLION)
TABLE 100. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY DISEASE MODELING, BY REGION, 2024-2030 (USD MILLION)
TABLE 101. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG SCREENING AND DEVELOPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 102. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG SCREENING AND DEVELOPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 103. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2023 (USD MILLION)
TABLE 104. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2024-2030 (USD MILLION)
TABLE 105. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY RESEARCH, BY REGION, 2018-2023 (USD MILLION)
TABLE 106. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY RESEARCH, BY REGION, 2024-2030 (USD MILLION)
TABLE 107. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2018-2023 (USD MILLION)
TABLE 108. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2024-2030 (USD MILLION)
TABLE 109. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2018-2023 (USD MILLION)
TABLE 110. GLOBAL CELL LINE DEVELOPMENT MARKET SIZE, BY TOXICITY TESTING, BY REGION, 2024-2030 (USD MILLION)
TABLE 111. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 112. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 113. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 114. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 115. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 116. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 117. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 118. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 119. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 120. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 121. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 122. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 123. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 124. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 125. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 126. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 127. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 128. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 129. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 130. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 131. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 132. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 133. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 134. AMERICAS CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 135. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 136. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 137. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 138. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 139. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 140. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 141. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 142. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 143. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 144. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 145. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 146. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 147. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 148. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 149. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 150. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 151. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 152. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 153. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 154. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 155. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 156. ARGENTINA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 157. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 158. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 159. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 160. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 161. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 162. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 163. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 164. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 165. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 166. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 167. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 168. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 169. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 170. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 171. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 172. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 173. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 174. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 175. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 176. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 177. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 178. BRAZIL CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 179. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 180. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 181. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 182. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 183. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 184. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 185. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 186. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 187. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 188. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 189. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 190. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 191. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 192. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 193. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 194. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 195. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 196. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 197. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 198. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 199. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 200. CANADA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 201. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 202. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 203. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 204. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 205. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 206. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 207. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 208. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 209. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 210. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 211. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 212. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 213. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 214. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 215. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 216. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 217. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 220. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 221. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 222. MEXICO CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 223. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 226. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 227. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 228. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 229. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 230. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 231. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 232. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 233. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 234. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 235. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 236. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 237. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 238. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 239. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 240. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 241. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 242. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 243. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 244. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 245. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 246. UNITED STATES CELL LINE DEVELOPMENT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 247. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 250. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 251. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 252. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 253. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 254. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 255. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 256. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 257. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 258. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 259. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 260. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 261. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 262. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 264. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 266. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 268. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 270. ASIA-PACIFIC CELL LINE DEVELOPMENT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 271. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 274. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 275. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 276. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 277. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 278. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 279. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 280. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 281. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 282. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 283. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 284. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 285. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 286. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 287. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 288. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 289. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 290. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 291. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 292. AUSTRALIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 293. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 294. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 295. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 296. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 297. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 298. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 299. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 300. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 301. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 302. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 303. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 304. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 305. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 306. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 307. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 308. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 309. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 310. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 311. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 312. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 313. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 314. CHINA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 315. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 316. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 317. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 318. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 319. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
TABLE 320. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
TABLE 321. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2018-2023 (USD MILLION)
TABLE 322. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY EQUIPMENT, 2024-2030 (USD MILLION)
TABLE 323. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2018-2023 (USD MILLION)
TABLE 324. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA AND REAGENTS, 2024-2030 (USD MILLION)
TABLE 325. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2018-2023 (USD MILLION)
TABLE 326. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY MEDIA, 2024-2030 (USD MILLION)
TABLE 327. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2018-2023 (USD MILLION)
TABLE 328. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY REAGENTS, 2024-2030 (USD MILLION)
TABLE 329. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2018-2023 (USD MILLION)
TABLE 330. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY SERUM, 2024-2030 (USD MILLION)
TABLE 331. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 332. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 333. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2018-2023 (USD MILLION)
TABLE 334. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY BIOPRODUCTION, 2024-2030 (USD MILLION)
TABLE 335. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2018-2023 (USD MILLION)
TABLE 336. INDIA CELL LINE DEVELOPMENT MARKET SIZE, BY DRUG DISCOVERY, 2024-2030 (USD MILLION)
TABLE 337. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 338. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 339. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2018-2023 (USD MILLION)
TABLE 340. INDONESIA CELL LINE DEVELOPMENT MARKET SIZE, BY SOURCE, 2024-2030 (USD MILLION)
TABLE 341. I

Companies Mentioned

  • Advanced Instruments, LLC
  • AGC Biologics
  • Aragen Life Sciences Ltd.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Corning Incorporated
  • Cyagen
  • Danaher Corporation
  • EuBiologics Co.,Ltd.
  • Eurofins Scientific
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • GE HealthCare Technologies Inc.
  • GenScript Biotech Corporation
  • KBI Biopharma by JSR Life Sciences, LLC
  • Lonza Group Ltd.
  • Merck KGaA
  • Novartis AG
  • PromoCell GmbH
  • Rentschler Biopharma SE
  • Samsung Biologics Co., Ltd.
  • Sartorius AG
  • Syngene International Ltd.
  • Thermo Fisher Scientific Inc.
  • Vista Biologicals Corporation
  • WuXi Biologics Co., Ltd.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 6.49 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.54 Billion
Compound Annual Growth Rate14.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services (Reagents And Media, Equipment), By Source (Mammalian, Non-mammalian), By Type of Cell Line, By Source, By Application, And Segment Forecasts, 2023 - 2030 - Product Image

Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services (Reagents And Media, Equipment), By Source (Mammalian, Non-mammalian), By Type of Cell Line, By Source, By Application, And Segment Forecasts, 2023 - 2030

  • Report
  • 180 Pages
  • Global
From
Cell Line Development - Global Strategic Business Report - Product Image

Cell Line Development - Global Strategic Business Report

  • Report
  • 193 Pages
  • Global
From
Cell Line Development Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Cell Line Development Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Cell Freezing Media Market Size, Share & Trends Analysis Report By Product (DMSO, Glycerol), By Application (Stem Cell Lines, Cancer Cell Lines), By End-use, By Region, And Segment Forecasts, 2023-2030 - Product Image

Cell Freezing Media Market Size, Share & Trends Analysis Report By Product (DMSO, Glycerol), By Application (Stem Cell Lines, Cancer Cell Lines), By End-use, By Region, And Segment Forecasts, 2023-2030

  • Report
  • 150 Pages
  • Global
From
Cell based Assays Market by Product & Service (Reagents, Assays Kits, Cell Lines, Microplates, Probes & Labels, Instruments & Software), Application (Drug Discovery (Toxicity, Pharmacokinetics), Research), End User (CROS, Pharma) & Region - Global Forecast to 2028 - Product Image

Cell based Assays Market by Product & Service (Reagents, Assays Kits, Cell Lines, Microplates, Probes & Labels, Instruments & Software), Application (Drug Discovery (Toxicity, Pharmacokinetics), Research), End User (CROS, Pharma) & Region - Global Forecast to 2028

  • Report
  • 340 Pages
  • Global
From

About the Market

The Cell Line Development market is a subset of the biotechnology industry that focuses on the development of cell lines for use in research and drug discovery. Cell lines are immortalized cell cultures that can be used to study the effects of drugs, toxins, and other compounds on cells. Cell lines are also used to produce biopharmaceuticals, such as monoclonal antibodies, vaccines, and gene therapies. Cell line development involves the selection, characterization, and optimization of cell lines for specific applications. This process includes the selection of the appropriate cell type, the optimization of culture conditions, and the characterization of the cell line for its suitability for the intended application. Companies in the Cell Line Development market include Thermo Fisher Scientific, Merck KGaA, Lonza, Sartorius AG, Corning Incorporated, and Charles River Laboratories. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.